Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Functional Proteomic Profiling Analysis in Four Major Types of Gastrointestinal Cancers

Open access
Wang, Yangyang, Gao, Xiaoguang, Wang, Jihan · 2023 · Biomolecules

Abstract

Gastrointestinal (GI) cancer accounts for one in four cancer cases and one in three cancer-related deaths globally. A deeper understanding of cancer development mechanisms can be applied to cancer medicine. Comprehensive sequencing applications have revealed the genomic landscapes of the common types of human cancer, and proteomics technology has identified protein targets and signalling pathways related to cancer growth and progression. This study aimed to explore the functional proteomic profiles of four major types of GI tract cancer based on The Cancer Proteome Atlas (TCPA). We provided an overview of functional proteomic heterogeneity by performing several approaches, including principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), t-stochastic neighbour embedding (t-SNE) analysis, and hierarchical clustering analysis in oesophageal carcinoma (ESCA), stomach adenocarcinoma (STAD), colon adenocarcinoma (COAD), and rectum adenocarcinoma (READ) tumours, to gain a system-wide understanding of the four types of GI cancer. The feature selection approach, mutual information feature selection (MIFS) method, was conducted to screen candidate protein signature subsets to better distinguish different cancer types. The potential clinical implications of candidate proteins in terms of tumour progression and prognosis were also evaluated based on TCPA and The Cancer Genome Atlas (TCGA) databases. The results suggested that functional proteomic profiling can identify different patterns among the four types of GI cancers and provide candidate proteins for clinical diagnosis and prognosis evaluation. We also highlighted the application of feature selection approaches in high-dimensional biological data analysis. Overall, this study could improve the understanding of the complexity of cancer phenotypes and genotypes and thus be applied to cancer medicine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biom13040701

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Overview of RPPA functional proteome profiling across ESCA, STAD, COAD, and READ tumour samples: (A) PCA plot, (B) PLS-DA plot, (C) t-SNE, and (D) heatmap showing clusters of tumour samples in ESCA, STAD, COAD, and READ based on all 217 protein profiles.
Figure 1 Overview of RPPA functional proteome profiling across ESCA, STAD, COAD, and READ tumour samples: (A) PCA plot, (B) PLS-DA plot, (C) t-SNE, and (D) heatmap showing clusters of tumour samples in ESCA, STAD, COAD, and READ based on all 217 protein profiles.CC BY · PubMed Central
Figure 2 RPPA relative abundances of the 20 selected protein signatures in ESCA, STAD, and CRC samples. Each violin plot shows the minimum, median, and maximum protein abundance in one tumour type. *** p < 0.0001 by ANOVA.
Figure 2 RPPA relative abundances of the 20 selected protein signatures in ESCA, STAD, and CRC samples. Each violin plot shows the minimum, median, and maximum protein abundance in one tumour type. *** p < 0.0001 by ANOVA.CC BY · PubMed Central
Figure 3 Clusters of tumour samples across ESCA, STAD, and CRC based on the 20 selected protein signatures: (A) PCA plot, (B) PLS-DA plot, (C) t-SNE, and (D) heatmap showing clusters of tumour samples in ESCA, STAD, and CRC.
Figure 3 Clusters of tumour samples across ESCA, STAD, and CRC based on the 20 selected protein signatures: (A) PCA plot, (B) PLS-DA plot, (C) t-SNE, and (D) heatmap showing clusters of tumour samples in ESCA, STAD, and CRC.CC BY · PubMed Central
Figure 4 Associations of protein biomarkers with tumour stage: (A) scatter plot of proteins MYH11, CD20, and HER_pY1289 in stages I/II/III/IV of ESCA tumours; (B) Spearman correlation analysis of proteins MYH11, CD20, and HER_pY1289 with tumour stage in ESCA; (C) scatter plot of proteins MYH11, CD20, and CHK1_pS345 in stages I/II/III/IV of STAD tumours; (D) Spearman correlation analysis of proteins MYH11, CD20, and CHK1_pS345 with tumour stage in STAD; (E) scatter plot of proteins ADAR1, HER3, and PREX1 in stages I/II/III/IV of CRC tumours; (F) Spearman correlation analysis of proteins ADAR1, HER3, and PREX1 with tumour stage in CRC.
Figure 4 Associations of protein biomarkers with tumour stage: (A) scatter plot of proteins MYH11, CD20, and HER_pY1289 in stages I/II/III/IV of ESCA tumours; (B) Spearman correlation analysis of proteins MYH11, CD20, and HER_pY1289 with tumour stage in ESCA; (C) scatter plot of proteins MYH11, CD20, and CHK1_pS345 in stages I/II/III/IV of STAD tumours; (D) Spearman correlation analysis of proteins MYH11, CD20, and CHK1_pS345 with tumour stage in STAD; (E) scatter plot of proteins ADAR1, HER3, and PREX1 in stages I/II/III/IV of CRC tumours; (F) Spearman correlation analysis of proteins ADAR1, HER3, and PREX1 with tumour stage in CRC.CC BY · PubMed Central
Figure 5 Forest plots of univariate Cox regression analysis in ESCA, STAD, and CRC tumours based on the corresponding clinical parameters. BMI: Body mass index. * p < 0.05, ** p < 0.01.
Figure 5 Forest plots of univariate Cox regression analysis in ESCA, STAD, and CRC tumours based on the corresponding clinical parameters. BMI: Body mass index. * p < 0.05, ** p < 0.01.CC BY · PubMed Central
Figure 6 Kaplan-Meier survival curves based on the candidate proteins: Kaplan-Meier survival curves showed that (A) two candidate proteins, (B) six candidate proteins, and (C) six candidate proteins were associated with overall survival in ESCA, STAD, and CRC patients, respectively. The horizontal axis represents survival time in days, and the vertical axis shows the overall survival rate.
Figure 6 Kaplan-Meier survival curves based on the candidate proteins: Kaplan-Meier survival curves showed that (A) two candidate proteins, (B) six candidate proteins, and (C) six candidate proteins were associated with overall survival in ESCA, STAD, and CRC patients, respectively. The horizontal axis represents survival time in days, and the vertical axis shows the overall survival rate.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

See all 9

Metadata

Authors
Wang, Y., Gao, X., & Wang, J.
Affiliations
Northwestern Polytechnical University (CN)
Corresponding author
  • Gao, Xiaoguang
  • Wang, Jihan
Venue
Biomolecules
Publisher
MDPI AG
Published
2023-04-20
Volume
13
Issue
4
Pages
701
ISSN
2218-273X (ISSN-L)
OpenAlex
W4366691770
Cited by
9
References
41
Citations by year
2026: 2 · 2025: 3 · 2024: 3 · 2023: 1
FWCI
0.83
Type
journal article
Language
en
Open access
Locations
  • Biomolecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81900134, 2021SF-030, LQ20H160009)
  • Shaanxi Provincial Key Research and Development Program (81900134, 2021SF-030, LQ20H160009)
  • Natural Science Foundation of Zhejiang Province (81900134, 2021SF-030, LQ20H160009)
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
gastrointestinal cancer, esophageal cancer, gastric adenocarcinoma, colon adenocarcinoma, rectal adenocarcinoma, proteomic signatures, mutual information feature selection, tumor progression, cancer prognosis
MeSH terms
Adenocarcinoma, Colonic Neoplasms, Humans, Proteins, Genomics, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Functional Proteomic Profiling Analysis in Four Major Types of Gastrointestinal Cancers. https://app.cochat.ai/papers/10.3390/biom13040701
The paper
Wang, Y., Gao, X., & Wang, J. (2023). Functional Proteomic Profiling Analysis in Four Major Types of Gastrointestinal Cancers. Biomolecules. https://doi.org/10.3390/biom13040701

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.